KLDO vs. GNCAQ, GNCA, ONCSQ, VIVE, HTGMQ, UTRS, AHPI, ATNFW, SXTPW, and DRTSW
Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), OncoSec Medical (ONCSQ), Viveve Medical (VIVE), HTG Molecular Diagnostics (HTGMQ), Minerva Surgical (UTRS), Allied Healthcare Products (AHPI), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical" sector.
Genocea Biosciences (NASDAQ:GNCAQ) and Kaleido Biosciences (NASDAQ:KLDO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership, community ranking and analyst recommendations.
Genocea Biosciences has higher revenue and earnings than Kaleido Biosciences.
81.6% of Kaleido Biosciences shares are owned by institutional investors. 1.6% of Genocea Biosciences shares are owned by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.
Genocea Biosciences has a beta of 2.28, suggesting that its share price is 128% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, suggesting that its share price is 106% less volatile than the S&P 500.
Kaleido Biosciences received 54 more outperform votes than Genocea Biosciences when rated by MarketBeat users.
Summary
Genocea Biosciences and Kaleido Biosciences tied by winning 3 of the 6 factors compared between the two stocks.
Get Kaleido Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kaleido Biosciences Competitors List
Related Companies and Tools
